Corpus ID: 40942796

Insulin therapy for type 2 diabetes: rescue, augmentation, and replacement of beta-cell function.

@article{Mayfield2004InsulinTF,
  title={Insulin therapy for type 2 diabetes: rescue, augmentation, and replacement of beta-cell function.},
  author={J. Mayfield and R. D. White},
  journal={American family physician},
  year={2004},
  volume={70 3},
  pages={
          489-500
        }
}
Type 2 diabetes is characterized by progressive beta-cell failure. [...] Key Method Basal insulin, using long-acting insulins (i.e., neutral protamine Hagedorn [NPH], ultralente, glargine) is injected once or twice a day and continued on sick days. Bolus (or mealtime) insulin, using short-acting or rapid-acting insulins (i.e., regular, aspart, lispro) covers mealtime carbohydrates and corrects the current glucose level. The starting dose of 0.15 units per kg per day for augmentation or 0.5 units per kg per day…Expand
Why, when and how to initiate insulin therapy in patients with type 2 diabetes
Physiologic Insulin Replacement in Type 2 Diabetes
Insulin initiation and intensification in patients with T2DM for the primary care physician
  • J. Unger
  • Medicine
  • Diabetes, metabolic syndrome and obesity : targets and therapy
  • 2011
EADSG Guidelines: Insulin Therapy in Diabetes
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 63 REFERENCES
...
1
2
3
4
5
...